Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOS1 | Q07889 | 1/20 | 0.58 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.58 |
| ▸ | SCN4A | P35499 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6290683 | 1.00 | SOS1 (0.58) | SOS1HSPB1SCN4AGAAMEN1 | |
| SCHEMBL6289867 | 1.00 | SOS1 (0.58) | SOS1HSPB1SCN4AGAAMEN1 | |
| SCHEMBL7367702 | 0.97 | SOS1 (0.56) | SOS1HSPB1SCN4AGAAMEN1 | |
| SCHEMBL31655464 | 0.91 | SOS1 (0.52) | SOS1HSPB1SCN4AGAAMEN1 | |
| SCHEMBL255272 | 0.88 | LTA4H (0.67) | SOS1HSPB1MEN1KMT2ATSHR | |
| Phosphine SCHEMBL23466364 | 0.86 | LTA4H (0.63) | SOS1HSPB1MEN1KMT2ATSHR | |
| SCHEMBL5175480 | 0.86 | NFE2L2 (0.64) | SOS1HSPB1MEN1KMT2AALDH1A1 | |
| SCHEMBL805908 | 0.86 | MAPT (0.58) | SOS1HSPB1SCN4AGAAMEN1 | |
| Ammonia Solution, Strong SCHEMBL4263312 | 0.86 | LTA4H (0.63) | SOS1HSPB1MEN1KMT2ATSHR | |
| SCHEMBL5175115 | 0.86 | MAOA (0.58) | SOS1HSPB1SCN4AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059903-A | Trifluoromethyl-containing fluorinated phenyl ether derivative, and preparation method and application thereof | 江西凯信生物医药有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-120192679-A | Ink, film, light-emitting device and display device | 广东聚华印刷显示技术有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119390953-B | Method for preparing polyether ketone and product obtained by same | 汕头大学 | 2025-04-04 | — | — | CN | claimed |
| CN-119390953-A | Method for preparing polyether ketone and product obtained by same | 汕头大学 | 2025-02-07 | — | — | CN | claimed |
| WO-2024221958-A1 | PREPARATION METHOD FOR MODIFIED POLYETHERSULFONE/POLYETHERIMIDE POLYMER ALLOY | 深圳先进技术研究院 | 2024-10-31 | — | — | WO | claimed |
| CN-118367211-A | Sodium ion battery electrolyte capable of inhibiting growth of sodium dendrite | 西北师范大学 | 2024-07-19 | — | — | CN | claimed |
| CN-117497858-A | Electrolyte and lithium ion battery | 蜂巢能源科技股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-116675861-A | Preparation method of modified polyethersulfone/polyetherimide polymer alloy | 深圳先进技术研究院 | 2023-09-01 | — | — | CN | claimed |
| CN-113429532-B | Application of polyether-ether-ketone prepared from 1-butyl-3-methylimidazole bromide in selective laser sintering | 江汉大学 | 2023-05-23 | — | — | CN | claimed |
| CN-113321800-B | Application of selective laser sintering by taking polyether-ether-ketone prepared from tetramethyl guanidine tetrafluoroborate as raw material | 江汉大学 | 2023-05-23 | — | — | CN | claimed |
| CN-107964079-A | A kind of preparation method of polyether-ether-ketone | 江汉大学 | 2018-04-27 | — | — | CN | claimed |
| US-8029850-B2 | Method of manufacturing organic electroluminescent device and method of manufacturing device | SEIKO EPSON CORPORATION (JP) | 2011-10-04 | — | — | US | claimed |
| US-6541647-B2 | Active materials; drugs; antiinflammatory agents; antiallergens | MILLENNIUM PHARMACEUTICALS, INC. | 2003-04-01 | — | — | US | claimed |
| US-20020035278-A1 | Methods for synthesis of substituted tetrahydrofuran compound | MILLENNIUM PHARMACEUTICALS, INC. | 2002-03-21 | — | — | US | claimed |
| CN-1070880-C | Method for preparing polyarylene sulfide with high molecular and high toughness | UNIV SICHUAN UNITED (CN) | 2001-09-12 | — | — | CN | claimed |
| EP-1102759-A1 | METHODS FOR SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN COMPOUND | Millennium Pharmaceuticals, Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| CN-1061666-C | Method for atmospheric prepn. of polyarylthio-ether by using Na hydrosulfide | UNIV SICHUAN UNITED (CN) | 2001-02-07 | — | — | CN | claimed |
| WO-2000001683-A1 | METHODS FOR SYNTHESIS OF SUBSTITUTED TETRAHYDROFURAN COMPOUND | LEUKOSITE, INC. (US) | 2000-01-13 | — | — | WO | claimed |
| CN-1145375-A | Method for atmospheric prepn. of polyarylthio-ether by using Na hydrosulfide | UNIV SICHUAN UNITED (CN) | 1997-03-19 | — | — | CN | claimed |
| CN-1143652-A | Method for preparing polyarylene sulfide with high molecular and high toughness | UNIV SICHUAN UNION (CN) | 1997-02-26 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035278-A1 | Methods for synthesis of substituted tetrahydrofuran compound | DHFR, CYP3A4, CYP3A5 | SOS1 3840/4885HSPB1 3449/4885SCN4A 1574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.